Paola Suatoni

Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study.

Assessment of circulating microRNAs in plasma of lung cancer patients.

Recent advances of microRNA-based molecular diagnostics to reduce false-positive lung cancer imaging.

Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening.

Novel method to detect microRNAs using chip-based QuantStudio 3D digital PCR.

Baseline C-reactive protein level predicts survival of early-stage lung cancer: evidence from a systematic review and meta-analysis.

C-reactive protein level predicts mortality in COPD: a systematic review and meta-analysis.

Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening-Detected Lung Cancers.

Inflammatory status and lung function predict mortality in lung cancer screening participants.

Baseline and postoperative C-reactive protein levels predict mortality in operable lung cancer.